UBS O'Connor’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-60,000
Closed -$868K 582
2013
Q2
$868K Buy
+60,000
New +$868K 0.02% 377